Crossmark

Preparation of semaglutide long-acting injectable microcapsules with physicochemical properties, long-term stability, and pharmacokinetics and pharmacodynamics

Crossref DOI link: https://doi.org/10.1007/s40005-024-00681-y

Published Online: 2024-05-29

Published Print: 2024-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Maharjan, Ravi

Lim, Duck Soo

Baik, Hye Jung

Park, Ha Eun

Kim, Min-Soo

Kim, Ki Hyun

Jeong, Seong Hoon
Funding

Funding for this research was provided by:

National Research Foundation of Korea (NRF-2019R1A2C1083911)

Dongguk University Research Fund of 2023 (S-2023-G0001-00099)
License Information

Text and Data Mining valid from 2024-05-29

Version of Record valid from 2024-05-29
More Information

Article History

Received: 29 January 2024

Accepted: 28 April 2024

First Online: 29 May 2024

Declarations

:

: All authors (Ravi Maharjan, Duck soo Lim, Hye Jung Baik, Ha Eun Park, Min-Soo Kim, Ki Hyun Kim, and Seong Hoon Jeong) declare that they have no conflict of interest.

: The protocol was approved from QuBEST BIO IACUC (QBIACUC-A22356) and NCEED IACUC (INHA 230209-854) prior to conducting the experiments.

Document is current

Any future updates will be listed below